- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Health Care & Insurance
WellPoint among 13 picked to join California exchange
May 23, 2013
Bloomberg NewsCalifornia residents who choose to buy health insurance through the state exchange being created by the Affordable Care Act
may end up paying higher premiums.
MoreForecast: Cash to reign in health care
May 20, 2013
J.K. WallWith premiums for health insurance likely to head north next year as President Obama’s health care reform law fully
takes effect, both individuals and employers will pay for more health care out of their own funds and buy less insurance.
MoreLilly study: 1 in 5 Alzheimer's patients misdiagnosed
May 20, 2013
J.K. WallThe study results, which will be released Monday afternoon, are part of Indianapolis-based Lilly’s campaign to get Medicare
to pay for use of its brain imaging agent Amyvid.
MoreWork stops on Greenwood pharmaceutical plant
May 20, 2013
IBJ Staff and Associated PressGreenwood officials three years ago approved $8.4 million of incentives for the Elona Biotechnologies project, including the
construction loan.
MoreMobile health apps could cut into state companies' market share
May 18, 2013
J.K. WallThe future of Indiana’s sprawling health care and life sciences industry might be threatened by an unlikely source:
smartphone apps.
MoreReport: Roche mulls sale of blood-glucose monitor business
May 17, 2013
J.K. WallRoche Diagnostics Corp. is considering a sale of its blood-glucose meter business, a move that would cast uncertainty over
the nearly 1,000 people working for its diabetes business in Indianapolis.
MorePANEL: Life sciences will see radically different future
May 17, 2013
IBJ convened a panel of experts at its Life Sciences Power Breakfast on May 10 to talk about the industry issues
of venture capital, digital health innovations and research university entrepreneurship.
MorePanel members included Kristin Eilenberg, CEO, Lodestone Logic, Infuse Accelerator; Philip S. Low, Purdue University professor of chemistry, founder and chief science officer at Endocyte Inc. and On Target Laboratories LLC; R. Matthew Neff, president, CHV Capital Inc.; Brian Stemme, project director; BioCrossroads; Brian S. Williams, director, Global Healthcare Strategy, PricewaterhouseCoopers International Ltd.; and Raul Zaveleta, CEO, Indigo BioSystems Inc.
The following is an unedited transcript of the discussion.
Canada’s Supreme Court won’t hear Lilly appeal on Zyprexa
May 16, 2013
Bloomberg NewsEli Lilly claims recent decisions by Canadian courts invalidating 17 drug patents have made the country an outlier among major
developed countries.
MoreIndianapolis couple charged with mail fraud
May 15, 2013
IBJ StaffGeorge Bowman, 43, and Traci L. Bowman, 42, are accused of falsifying purchase records and fraudulently filing insurance claims
for expensive construction equipment they never purchased.
MoreSurprise director departures boost WellPoint shares
May 14, 2013
Greg AndrewsOutside observers cast the departures of Lenox Baker, Sheila Burke and Susan Bayh as a positive that will allow new CEO Joseph
Swedish to recast the board.
MoreLechleiter's surgery to repair heart goes as planned
May 14, 2013
Bloomberg NewsEli Lilly and Co. CEO John Lechleiter underwent a scheduled surgery Monday for a heart defect, and the repair to the aorta
is functioning as intended, the Indianapolis-based drugmaker said.
MoreThree WellPoint directors step down, cite personal reasons
May 13, 2013
Bloomberg NewsLenox Baker, Sheila Burke and Susan Bayh resigned from the board effective immediately, Indianapolis-based WellPoint said
Monday in a regulatory filing.
MoreMichigan doctor named dean of IU School of Medicine
May 13, 2013
Associated PressDr. Jay Hess was picked to become the 10th dean in the school of medicine's 110-year history and the first dean in the past
five to come from outside IU.
MoreIndiana device makers absorbing Obamacare excise tax
May 13, 2013
J.K. WallThe state's medical-device companies are finding that they cannot pass on the new medical-device tax created by Obamacare
to their hospital customers, causing them to continue to make cuts and to look to foreign markets for more profitable growth.
MoreStudy rebuts hospitals' argument on Medicare, rising costs
May 13, 2013
Rather than raising prices on private health insurers to make up for inadequate payments from the government, hospitals across
the country have been raising prices just because they can, according to a new study.
MoreTruck insurer’s new jobs to boast gold-plated pay
May 11, 2013
The 133 full-time jobs the truck and auto insurer plans to add over the next five years will pay around $60 an hour, or nearly
$125,000 a year.
MoreRuling keeps church ensnared in life insurance nightmare
May 11, 2013
Greg AndrewsA federal bankruptcy judge has slapped down an Anderson church that attempted to blame its bank for a failed scheme to finance
church upgrades by buying life insurance policies on its elderly members.
MoreLilly stops development on cancer drug after failed study
May 10, 2013
Bloomberg NewsThe drug, enzastaurin, was in the most advanced stage of testing and had been expected to generate $260 million in annual
sales by 2018.
MoreWarner Transitional Services to close, lay off 112
May 8, 2013
IBJ StaffWarner relies on funds from the Indiana Family and Social Administration, but the FSSA recently decided to end that funding
after numerous complaints against the company went unresolved.
MoreGovernor taps ex-WellPoint CEO Braly for IEDC board
May 7, 2013
J.K. WallThe appointment is the first high-profile post that Braly, 51, has accepted since she was ousted from the top spot at the
Indianapolis-based health insurer in August.
MoreIndiana firms lose ground on Fortune 500 list
May 7, 2013
Mason KingFive of the six Hoosier firms that appear in the 2013 rankings slipped from their positions in last year's list of the largest
U.S. companies.
MoreLilly CEO to step down temporarily due to surgery
May 6, 2013
J.K. WallJohn Lechleiter has been suffering from a dilated aorta, Eli Lilly and Co. said Monday. Current CFO Derica Rice will take
his place until later this summer.
MoreBiosciences institute aims for $300M endowment
May 6, 2013
J.K. WallThe effort to launch the Indiana Biosciences Research Institute got $25 million from the Legislature, but the life sciences
institutions backing the effort have set their funding sights much higher.
MoreLilly's sales-force restructuring to affect 1,600-plus
May 6, 2013
J.K. WallLilly will eliminate 1,624 positions from its U.S. sales force in July, according to a notice the company made to state officials.
But some of those workers may be rehired by the firm.
MoreLilly taking hard look at Pfizer's new Viagra strategy
May 6, 2013
Associated PressMajor drugmakers, including Indianapolis-based Eli Lilly and Co., are closely watching Pfizer Inc.'s plan to sell Viagra directly
to consumers. The bold move blows up the drug industry's distribution model.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
Just because someone supports the project, they are a PR shill for the developer? Myself and everyone I know has no connection whatsoever to any developer. We just want Broad Ripple to move forward and develop, not stay stagnant.
And the failure on the part of Indiana GOP to allow an expansion of Medicaid had nothing to do with Indiana hospitals' financial woes?
It would have been nice if they could have arranged for at least some of Zaxby's menu to be sold at the concession stands as part of the marketing campaign.
Get the feeling Browning has some PR presence on the message board this morning. I don't know a single person in the neighborhood who supports this project.
Grew up in Warfleigh, which is the neighborhood directly across College from the proposed development. I am against the proposed project for several reasons: 1) Traffic Flow -- College is already a mess, especially with the new lane guidance which makes the southbound left lane 'turn only' at Broad Ripple Ave. Not to mention the backups at 64th and College. If this is in fact a Whole Foods, I would expect a steady stream of cars pulling in and out, either off College or 64th Street which are both bad already. 2) Use of TIF funds. I though TIF funds were for under-developed areas, to help bolster property tax rolls for the city. I agree with Barth that this area will do just fine letting market forces dictate what is developed. 3) Specialty Grocer Overkill. There is already a Fresh Market a mile south and a Whole Foods 2 miles north. This store is not needed. Frankly I shocked that the Whole Foods site selection criteria supports a store right here 4) Hurts the Character of the Neighborhood. This type of development, along with the (hideous) parking garage down the street are out of character with the history and fabric of this area. Broad Ripple has succeeded because it was quirky and different. It would be a shame if the city gets involved and helps support ANOTHER project that aims to turn Broad Ripple into some kind of manufactured urban center.